Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes – a study in both people with type 2 diabetes and healthy subjects

AIMS: Glucagon-like peptide-1 (GLP-1) receptor agonists improve blood glucose control by enhancing glucose-sensitive insulin release, delaying gastric emptying and reducing postprandial glucagon secretion. The studies reported here investigated the insulin response to an intravenous (iv) glucose cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, R H A, Stechl, J, Msihid, J, Kapitza, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237545/
https://www.ncbi.nlm.nih.gov/pubmed/24521245
http://dx.doi.org/10.1111/dom.12278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237545/
https://www.ncbi.nlm.nih.gov/pubmed/24521245
http://dx.doi.org/10.1111/dom.12278

Ejemplares similares